Professional Documents
Culture Documents
Cholera Drug Study
Cholera Drug Study
Cholera Drug Study
Mechanism of action
Binds to ribosomal receptor sites of susceptible organisms, inhibiting RNA dependent protein synthesis.
Therapeutic Effect: Bacteriostatic or bactericidal, depending on drug dosage.
Indication
used to treat many different types of infections caused by bacteria, such as respiratory infections, skin
infections, ear infections, eye infections, and sexually transmitted diseases. Findings state that it may also
be used as an adjunct to hydration treatment for cholera
Contraindication
No contraindication indicated in the scenario but may include patients with:
- Renal dysfunction, hypokalemia, hypomagnesemia, bradycardia, dysrhythmias
Side Effect
No side effects give in the scenario, but common are:
- Nausea
- Dizziness
- Abdominal cramp
- Fatigue
Nursing Consideration:
Before:
Assess vital signs
Check apical pulse
Infuse slowly to avoid unnecessary pain (phlebitis)
Assess for allergies by skin test
During:
WOF: symptoms of hepatotoxicity
Check IV site
After:
Instruct patient to report adverse reactions promptly
Monitor vital signs & urine output
Monitor symptoms of high plasma potassium levels
Monitor daily pattern of bowel activity and stool consistency
Reference: Centers for Disease Control and Prevention. (2020, October 2). Antibiotic treatment. Centers
for Disease Control and Prevention. Retrieved November 13, 2021, from
https://www.cdc.gov/cholera/treatment/antibiotic-treatment.html.
Generic Name: Ceftriaxone
Classification: Third-generation cephalosporin
Dosage: 2g
Route: TIV
Frequency: OD
Mechanism of action
Binds to the bacterial cell wall membrane, causing cell death. Therapeutic Effect: Bactericidal action
against susceptible bacteria.
Indication
Used for treating otitis media, meningitis, gonorrhea, septicemia, UTI.
Also effective against Klebsiella, Haemophilus, Staphylococci and Escherichia coli
Contraindication
No contraindication indicated in the scenario but may include patients with:
- Hypersensitivity to penicillin/cephalosporin
- Bleeding, Vit. K deficiency, Diabetes Mellitus
Side Effect
No side effects given in the scenario, but common are:
- Anorexia
- Nausea
- Headache
- Dizziness
- Diarrhea
Nursing Consideration:
Before:
Assess for allergies (by skin testing)
During:
Instruct patient to increase fluid intake
Check IV site (for signs of phlebitis)
Observe stool consistency
After:
Monitor patient for signs and symptoms of superinfection
Monitor patient for bleeding
Advise patient to report adverse reactions promptly
WOF: seizure
Ceftriaxone. Ceftriaxone | Davis's Drug Guide for Rehabilitation Professionals | F.A. Davis PT Collection |
McGraw Hill Medical. (n.d.). Retrieved November 13, 2021, from
https://fadavispt.mhmedical.com/content.aspx?bookid=1873§ionid=139004956.
Generic Name: Ceftriaxone
Classification: Interkulin-6 receptor inhibitor
Dosage: 4mg
Frequency: OD
Mechanism of action
Binds to the bacterial cell wall membrane, causing cell death. Therapeutic Effect: Bactericidal action
against susceptible bacteria.
Indication
Used for treating otitis media, meningitis, gonorrhea, septicemia, UTI.
Also effective against Klebsiella, Haemophilus, Staphylococci and Escherichia coli
Contraindication
No contraindication indicated in the scenario but may include patients with:
- Hypersensitivity to penicillin/cephalosporin
- Bleeding, Vit. K deficiency, Diabetes Mellitus
Side Effect
No side effects given in the scenario, but common are:
- Anorexia
- Nausea
- Headache
- Dizziness
- Diarrhea
Nursing Consideration:
Before:
Assess for allergies (by skin testing)
During:
Instruct patient to increase fluid intake
Check IV site (for signs of phlebitis)
Observe stool consistency
After:
Monitor patient for signs and symptoms of superinfection
Monitor patient for bleeding
Advise patient to report adverse reactions promptly
WOF: seizure